Schedule 13D ownership disclosure

ALPINE IMMUNE SCIENCES INC

Security class unavailable · CUSIP: 02083G100

Event date: 2020-07-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-20-000655
Form type
SC 13D/A
Filer
ALPINE IMMUNE SCIENCES, INC.
CIK
CIK 1626199
Filed
Jul 30, 2020
Reporting period
Jul 28, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub